Chaojie Chen
No ORCID on file
· 1 paper in corpus
· active 2021
Elagolix, as a competitive gonadotropin-releasing hormone (GnRH) receptor antagonist, has been recently approved by the US FDA for the management of moderate to severe pain due to endometriosis in women. In this study, we developed and veri…